These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1878699)

  • 1. BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patients.
    Guerrasio A; Zaccaria A; Rosso C; Scaravaglio P; Rege Cambrin G; Bertolli VG; Saglio G; Tassinari A; Testoni N; Rosti G
    Bone Marrow Transplant; 1991; 7 Suppl 2():22. PubMed ID: 1878699
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of BCR/ABL transcripts after BMT for CML detected by PCR reflects a high risk of relapse.
    Hughes TP; O'Shea P; Morgan G; Martiat P; Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():23. PubMed ID: 1878700
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of chimeric transcript detection in CML patients after bone marrow transplantation.
    Martinelli G; Sessarego M; Gasparini P; Ambrosetti A; Frassoni F; Chiamenti AM; Pignatti PF
    Bone Marrow Transplant; 1991; 7 Suppl 2():21. PubMed ID: 1878698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia.
    Kohler S; Galili N; Sklar JL; Donlon TA; Blume KG; Cleary ML
    Leukemia; 1990 Aug; 4(8):541-7. PubMed ID: 2201832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
    Frassoni F; Martinelli G; Saglio G; Sessarego M; Podestà M; Piaggio G; Farabegoli P; Zaccaria A; Testoni N; Remiddi C
    Bone Marrow Transplant; 1995 Oct; 16(4):595-601. PubMed ID: 8528178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of bcr-abl transcripts in "minimal residual disease" in chronic myelogenous leukemia by nested polymerase chain reaction (PCR)].
    Cathomas G; McGandy C; Diamantis I; Tichelli A; Gudat F
    Verh Dtsch Ges Pathol; 1994; 78():314-7. PubMed ID: 7534004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical factors that affect the detection of BCR-ABL transcripts after allogenic bone marrow transplantation for chronic myeloid leukemia].
    Román J; García MJ; Martín C; Sánchez J; Serrano J; Falcón M; Castillejo JA; Navarro JA; Flores R; Torres A
    Med Clin (Barc); 1998 Oct; 111(11):405-9. PubMed ID: 9834912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of bcr-abl mRNA during long-term follow-up of cases of chronic myelogenous leukemia].
    Nakamura K; Okamoto N; Mizutani S
    Rinsho Ketsueki; 1994 Sep; 35(9):853-61. PubMed ID: 7967054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of T-depleted BMT in chronic myelogenous leukaemia after a conditioning regimen that included thiotepa.
    Aversa F; Pelicci PG; Terenzi A; Carotti A; Felicini R; Mencarelli A; Donti E; Latini P; Aristei C; Martelli MF
    Bone Marrow Transplant; 1991; 7 Suppl 2():24. PubMed ID: 1908727
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction.
    Hanson CA; Holbrook EA; Sheldon S; Schnitzer B; Roth MS
    Am J Pathol; 1990 Jul; 137(1):1-6. PubMed ID: 2196814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.